Skurikhin, E.G.; Pershina, O.; Ermakova, N.; Pakhomova, A.; Widera, D.; Zhukova, M.; Pan, E.; Sandrikina, L.; Kogai, L.; Kushlinskii, N.;
et al. Reprogrammed CD8+ T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer. Biomedicines 2022, 10, 1450.
https://doi.org/10.3390/biomedicines10061450
AMA Style
Skurikhin EG, Pershina O, Ermakova N, Pakhomova A, Widera D, Zhukova M, Pan E, Sandrikina L, Kogai L, Kushlinskii N,
et al. Reprogrammed CD8+ T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer. Biomedicines. 2022; 10(6):1450.
https://doi.org/10.3390/biomedicines10061450
Chicago/Turabian Style
Skurikhin, Evgenii G., Olga Pershina, Natalia Ermakova, Angelina Pakhomova, Darius Widera, Mariia Zhukova, Edgar Pan, Lubov Sandrikina, Lena Kogai, Nikolai Kushlinskii,
and et al. 2022. "Reprogrammed CD8+ T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer" Biomedicines 10, no. 6: 1450.
https://doi.org/10.3390/biomedicines10061450
APA Style
Skurikhin, E. G., Pershina, O., Ermakova, N., Pakhomova, A., Widera, D., Zhukova, M., Pan, E., Sandrikina, L., Kogai, L., Kushlinskii, N., Morozov, S. G., Kubatiev, A., & Dygai, A.
(2022). Reprogrammed CD8+ T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer. Biomedicines, 10(6), 1450.
https://doi.org/10.3390/biomedicines10061450